trimethoprim  (Gold Biotechnology Inc)


Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc trimethoprim
    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    1) Product Images from "Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates"

    Article Title: Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

    Journal: Antibiotics

    doi: 10.3390/antibiotics11101298

    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    Figure Legend Snippet: Summary of A. baumannii susceptibility to standard-of-care antibiotics.

    Techniques Used:

    Quantity of drugs used for disc preparations.
    Figure Legend Snippet: Quantity of drugs used for disc preparations.

    Techniques Used:

    Starting “X” concentration of drugs for the MIC determination.
    Figure Legend Snippet: Starting “X” concentration of drugs for the MIC determination.

    Techniques Used: Concentration Assay

    trimethoprim  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc trimethoprim
    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    1) Product Images from "Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates"

    Article Title: Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

    Journal: Antibiotics

    doi: 10.3390/antibiotics11101298

    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    Figure Legend Snippet: Summary of A. baumannii susceptibility to standard-of-care antibiotics.

    Techniques Used:

    Quantity of drugs used for disc preparations.
    Figure Legend Snippet: Quantity of drugs used for disc preparations.

    Techniques Used:

    Starting “X” concentration of drugs for the MIC determination.
    Figure Legend Snippet: Starting “X” concentration of drugs for the MIC determination.

    Techniques Used: Concentration Assay

    trimethoprim  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc trimethoprim
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    trimethoprim  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc trimethoprim
    Mouse model exhibiting cranial neural tube defect after <t>trimethoprim</t> exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    1) Product Images from "Cranial neural tube defect after trimethoprim exposure"

    Article Title: Cranial neural tube defect after trimethoprim exposure

    Journal: BMC Research Notes

    doi: 10.1186/s13104-018-3593-1

    Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively
    Figure Legend Snippet: Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively

    Techniques Used: Standard Deviation, Mass Spectrometry

    t 350  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc t 350
    T 350, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t 350/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    t 350 - by Bioz Stars, 2024-05
    92/100 stars

    Images

    pure trimethoprim  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc pure trimethoprim
    Mouse model exhibiting cranial neural tube defect after <t>trimethoprim</t> exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively
    Pure Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pure trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pure trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    1) Product Images from "Cranial neural tube defect after trimethoprim exposure"

    Article Title: Cranial neural tube defect after trimethoprim exposure

    Journal: BMC Research Notes

    doi: 10.1186/s13104-018-3593-1

    Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively
    Figure Legend Snippet: Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively

    Techniques Used: Standard Deviation, Mass Spectrometry

    trimethoprim  (Gold Biotechnology Inc)


    Bioz Verified Symbol Gold Biotechnology Inc is a verified supplier
    Bioz Manufacturer Symbol Gold Biotechnology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Gold Biotechnology Inc trimethoprim
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    Gold Biotechnology Inc trimethoprim
    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    trimethoprim - by Bioz Stars, 2024-05
    92/100 stars
      Buy from Supplier

    92
    Gold Biotechnology Inc t 350
    Summary of A. baumannii susceptibility to standard-of-care antibiotics.
    T 350, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t 350/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    t 350 - by Bioz Stars, 2024-05
    92/100 stars
      Buy from Supplier

    92
    Gold Biotechnology Inc pure trimethoprim
    Mouse model exhibiting cranial neural tube defect after <t>trimethoprim</t> exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively
    Pure Trimethoprim, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pure trimethoprim/product/Gold Biotechnology Inc
    Average 92 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    pure trimethoprim - by Bioz Stars, 2024-05
    92/100 stars
      Buy from Supplier

    Image Search Results


    Summary of A. baumannii susceptibility to standard-of-care antibiotics.

    Journal: Antibiotics

    Article Title: Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

    doi: 10.3390/antibiotics11101298

    Figure Lengend Snippet: Summary of A. baumannii susceptibility to standard-of-care antibiotics.

    Article Snippet: Antibiotics were purchased as follows: meropenem, imipenem, sulbactam, ceftazidime, tigecycline, doxycycline, colistin, and rifampin from Millipore-Sigma (Burlington, MA, USA); amikacin, minocycline, ampicillin, pipercillin, tazobactam, ceftriaxone, and gentamicin from GoldBio (St. Louis, MO, USA); trimethoprim, tobramycin and tetracycline Bio Basic (Amherst, NY, USA); polymyxin B from Research Products International (Mt.

    Techniques:

    Quantity of drugs used for disc preparations.

    Journal: Antibiotics

    Article Title: Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

    doi: 10.3390/antibiotics11101298

    Figure Lengend Snippet: Quantity of drugs used for disc preparations.

    Article Snippet: Antibiotics were purchased as follows: meropenem, imipenem, sulbactam, ceftazidime, tigecycline, doxycycline, colistin, and rifampin from Millipore-Sigma (Burlington, MA, USA); amikacin, minocycline, ampicillin, pipercillin, tazobactam, ceftriaxone, and gentamicin from GoldBio (St. Louis, MO, USA); trimethoprim, tobramycin and tetracycline Bio Basic (Amherst, NY, USA); polymyxin B from Research Products International (Mt.

    Techniques:

    Starting “X” concentration of drugs for the MIC determination.

    Journal: Antibiotics

    Article Title: Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates

    doi: 10.3390/antibiotics11101298

    Figure Lengend Snippet: Starting “X” concentration of drugs for the MIC determination.

    Article Snippet: Antibiotics were purchased as follows: meropenem, imipenem, sulbactam, ceftazidime, tigecycline, doxycycline, colistin, and rifampin from Millipore-Sigma (Burlington, MA, USA); amikacin, minocycline, ampicillin, pipercillin, tazobactam, ceftriaxone, and gentamicin from GoldBio (St. Louis, MO, USA); trimethoprim, tobramycin and tetracycline Bio Basic (Amherst, NY, USA); polymyxin B from Research Products International (Mt.

    Techniques: Concentration Assay

    Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively

    Journal: BMC Research Notes

    Article Title: Cranial neural tube defect after trimethoprim exposure

    doi: 10.1186/s13104-018-3593-1

    Figure Lengend Snippet: Mouse model exhibiting cranial neural tube defect after trimethoprim exposure. a Control mouse embryo (untreated) at E10.5 (24 somites stage) age matched against b mouse embryo with exencephaly at E10.5 (23 somites stage) harvested from TELSE tablet (0.5% w/v containing 0.1% w/v trimethoprim) administered female CD1 mouse. The arrows indicate the open cranial neural tube. c Mouse embryo with cranial neural tube defect at E10.5 (22 somites stage) harvested from pure trimethoprim (containing 0.05% w/v trimethoprim) administered female CD1 mouse. d Transverse section through the cranial region of embryo C showing open hindbrain (Scale bar for A-C represent 0.5 mm and D represent 0.1 mm). e TELSE tablet administered female CD1 mouse showed significantly increased number of exencephalic embryos (n = 8) compared to control embryos (n = 24) (*P < 0.0001) (ANOVA). f , g No significant differences were seen between crown-rump length and number of somites in the E10.5 embryos between affected (n = 8) and not affected embryos of both treated mice (n = 14) and untreated mice (n = 24) (P < 0.0001) (ANOVA) (Value of bars are medians ± standard deviation). h , i Chromatogram of trimethoprim showed a single peak at 1.54 min and mass spectrometry analysis of the TELSE tablet confirmed the presence of trimethoprim as the active compound, with an exact mass of 291 and 230 for parent and daughter ions respectively

    Article Snippet: An additional study using pure trimethoprim (GoldBio ® ) were performed at the concentrations of 0.1% w/v (Group Four) and 0.05% w/v (Group Five).

    Techniques: Standard Deviation, Mass Spectrometry